Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 27th:
Cleveland-Cliffs Inc. (CLF - Free Report) : This owner and operator of an iron ore mining company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 41% over the last 60 days.
Cleveland-Cliffs Inc. Price and Consensus
Cleveland-Cliffs’ shares gained 28.7% over the last one month more than S&P 500’s gain of 4.5%. The company possesses a Momentum Score of B.
Cleveland-Cliffs Inc. Price
Align Technology, Inc. (ALGN - Free Report) : This designer and manufacturer of clear aligner therapy systems and intraoral scanners has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings climbing 3.6% over the last 60 days.
Align Technology, Inc. Price and Consensus
Align Technology’s shares gained 5.6% over the last one month. The company possesses a Momentum Score of A.
Align Technology, Inc. Price
BioLife Solutions, Inc. (BLFS - Free Report) : This developer of medical instruments has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping more than 100% over the last 60 days.
BioLife Solutions, Inc. Price and Consensus
BioLife’s shares gained 80.8% over the last one month. The company possesses a Momentum Score of A.
BioLife Solutions, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 27th:
Cleveland-Cliffs Inc. (CLF - Free Report) : This owner and operator of an iron ore mining company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 41% over the last 60 days.
Cleveland-Cliffs Inc. Price and Consensus
Cleveland-Cliffs’ shares gained 28.7% over the last one month more than S&P 500’s gain of 4.5%. The company possesses a Momentum Score of B.
Cleveland-Cliffs Inc. Price
Align Technology, Inc. (ALGN - Free Report) : This designer and manufacturer of clear aligner therapy systems and intraoral scanners has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings climbing 3.6% over the last 60 days.
Align Technology, Inc. Price and Consensus
Align Technology’s shares gained 5.6% over the last one month. The company possesses a Momentum Score of A.
Align Technology, Inc. Price
BioLife Solutions, Inc. (BLFS - Free Report) : This developer of medical instruments has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping more than 100% over the last 60 days.
BioLife Solutions, Inc. Price and Consensus
BioLife’s shares gained 80.8% over the last one month. The company possesses a Momentum Score of A.
BioLife Solutions, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ALGN - FREE
Get the latest research report on CLF - FREE
Get the latest research report on BLFS - FREE